ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: GSK

Narcolepsy link to Glaxo vaccine poses challenge for FDA

Narcolepsy link to Glaxo vaccine poses challenge for FDA

March 7, 2013 5:01 pm by | 0 Comments

(Reuters) - Growing evidence of a link between GlaxoSmithKline Plc's pandemic flu vaccine and an increase in narcolepsy cases among children who received it in Europe, is giving pause to ... Read more
GlaxoSmithKline files for European approval of diabetes drug albiglutide

GlaxoSmithKline files for European approval of diabetes drug albiglutide

March 7, 2013 7:08 am by | 0 Comments

LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline said on Thursday it had filed for European approval of its new once-weekly diabetes drug albiglutide, as tries to gain a foothold in ... Read more
GlaxoSmithKline unit joins patent pool for AIDS drugs

GlaxoSmithKline unit joins patent pool for AIDS drugs

February 27, 2013 9:00 am by | 0 Comments

LONDON (Reuters) - GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries.ViiV ... Read more
UK study confirms GSK flu shot link to rare sleep disorder

UK study confirms GSK flu shot link to rare sleep disorder

February 26, 2013 6:30 pm by | 0 Comments

GlaxoSmithKline's Pandemrix swine flu vaccine has been linked to cases of the rare sleep disorder narcolepsy in children in a scientific study in England that confirms similar findings elsewhere in ... Read more
Flu vaccine worked in just over half of Americans who got it

Flu vaccine worked in just over half of Americans who got it

February 21, 2013 2:14 pm by | 3 Comments

CHICAGO (Reuters) - A U.S. government analysis of this season's flu vaccine suggests it was effective in only 56 percent of people who got the shot, and it completely failed ... Read more
GSK wins priority status for new HIV drug in U.S.

GSK wins priority status for new HIV drug in U.S.

February 15, 2013 11:16 am by | 0 Comments

LONDON (Reuters) - U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible multibillion-dollar-a-year seller.The U.S. Food and Drug Administration ... Read more
Drugmakers eye Africa’s middle classes as next growth market

Drugmakers eye Africa’s middle classes as next growth market

February 12, 2013 2:30 am by | 0 Comments

For pharmaceutical companies, Africa is changing.

Not only is the continent's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is luring Big Pharma, as new ... Read more

GSK expands academic collaboration initiative, backs drug to treat severe obesity

GSK expands academic collaboration initiative, backs drug to treat severe obesity

February 11, 2013 7:03 pm by | 0 Comments

In the past couple of years big pharmaceutical companies have been reaching out to universities to replenish their drug development pipelines. Vanderbilt University said it would be working with GlaxoSmithKline ... Read more
Glaxo’s chief “thrilled” at reaction to move to Navy Yard

Glaxo’s chief “thrilled” at reaction to move to Navy Yard

February 7, 2013 5:10 am by | 0 Comments

GlaxoSmithKline reported lower fourth-quarter profits Wednesday and said it would consider selling off two soft-drink brands popular in the United Kingdom, but chief executive officer Andrew Witty said he was ... Read more
GSK promises growth this year after 2012 shortfall

GSK promises growth this year after 2012 shortfall

February 6, 2013 7:13 am by | 0 Comments

LONDON (Reuters) - GlaxoSmithKline, Britain's biggest drugmaker, renewed its promise to return to growth this year, after failing to deliver a hoped-for sales and margin recovery in 2012.GSK also announced ... Read more
GSK promises to publish detailed drug trial data

GSK promises to publish detailed drug trial data

February 5, 2013 10:34 am by | 0 Comments

LONDON (Reuters) - British drugmaker GlaxoSmithKline, which paid $3 billion last year to settle charges that it gave misleading information on its medicines, said on Tuesday it would publish more ... Read more
Swine flu shot may be linked to narcolepsy in kids

Swine flu shot may be linked to narcolepsy in kids

January 26, 2013 10:55 am by | 0 Comments

STOCKHOLM, Jan 22 (Reuters) - Emelie is plagued by hallucinations and nightmares. When she wakes up, she's often paralysed, unable to breathe properly or call for help. During the day ... Read more
GSK, Mayo, Roche and others join to study and treat early victims of child sex abuse

GSK, Mayo, Roche and others join to study and treat early victims of child sex abuse

October 11, 2012 12:45 pm by | 0 Comments

ZURICH (Reuters) - Leading drugmakers will help set up psychological centers for victims of child sex abuse in an effort to counter the long-term health problems suffered by victims. Roche, ... Read more
GSK will open up drug data; information includes patient data on failed trials

GSK will open up drug data; information includes patient data on failed trials

October 11, 2012 2:57 am by | 1 Comments

LONDON (Reuters) - GlaxoSmithKline, criticized in the past for keeping important information about its medicines under wraps, is to lift the lid on more of its drug secrets.Chief executive Andrew ... Read more
GSK moving ahead with ‘proof of concept’ tuberculosis vaccine

GSK moving ahead with ‘proof of concept’ tuberculosis vaccine

October 10, 2012 7:09 am by | 0 Comments

LONDON (Reuters) - GlaxoSmithKline and the non-profit biotech group Aeras are to assess an experimental tuberculosis vaccine in "proof of concept" tests in Africa and India, marking a step forward ... Read more